GO:0016020 | membrane | 1.54e-04 | 1.00e+00 | 2.753 | 5 | 38 | 1207 |
GO:0071013 | catalytic step 2 spliceosome | 5.67e-04 | 1.00e+00 | 5.738 | 2 | 5 | 61 |
GO:0004151 | dihydroorotase activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0016363 | nuclear matrix | 8.11e-04 | 1.00e+00 | 5.479 | 2 | 7 | 73 |
GO:0005829 | cytosol | 1.04e-03 | 1.00e+00 | 2.187 | 5 | 58 | 1787 |
GO:0006543 | glutamine catabolic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0000015 | phosphopyruvate hydratase complex | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0004634 | phosphopyruvate hydratase activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0051414 | response to cortisol | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0000398 | mRNA splicing, via spliceosome | 2.47e-03 | 1.00e+00 | 4.668 | 2 | 8 | 128 |
GO:0014075 | response to amine | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0000812 | Swr1 complex | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 2 | 7 |
GO:0031122 | cytoplasmic microtubule organization | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 8 |
GO:0031011 | Ino80 complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 8 |
GO:0032479 | regulation of type I interferon production | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 9 |
GO:0008266 | poly(U) RNA binding | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0006541 | glutamine metabolic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0035458 | cellular response to interferon-beta | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 10 |
GO:0043968 | histone H2A acetylation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 10 |
GO:0043234 | protein complex | 6.52e-03 | 1.00e+00 | 3.954 | 2 | 8 | 210 |
GO:0007020 | microtubule nucleation | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 3 | 12 |
GO:0031430 | M band | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 1 | 14 |
GO:0070062 | extracellular vesicular exosome | 8.95e-03 | 1.00e+00 | 1.988 | 4 | 43 | 1641 |
GO:0044822 | poly(A) RNA binding | 9.04e-03 | 1.00e+00 | 2.611 | 3 | 25 | 799 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 17 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0003678 | DNA helicase activity | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 18 |
GO:0071339 | MLL1 complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0000794 | condensed nuclear chromosome | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 18 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0005524 | ATP binding | 1.23e-02 | 1.00e+00 | 2.453 | 3 | 23 | 892 |
GO:0017144 | drug metabolic process | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0043967 | histone H4 acetylation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 22 |
GO:0006096 | glycolytic process | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 2 | 29 |
GO:0042802 | identical protein binding | 1.78e-02 | 1.00e+00 | 3.201 | 2 | 7 | 354 |
GO:0006094 | gluconeogenesis | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0043195 | terminal bouton | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0007595 | lactation | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 32 |
GO:0000226 | microtubule cytoskeleton organization | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 36 |
GO:0040008 | regulation of growth | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 2 | 37 |
GO:0035690 | cellular response to drug | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 2 | 38 |
GO:0032508 | DNA duplex unwinding | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 40 |
GO:0042995 | cell projection | 2.49e-02 | 1.00e+00 | 5.311 | 1 | 2 | 41 |
GO:0004386 | helicase activity | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 42 |
GO:0031100 | organ regeneration | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 44 |
GO:0032481 | positive regulation of type I interferon production | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 5 | 48 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 3 | 49 |
GO:0006310 | DNA recombination | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 6 | 50 |
GO:0006334 | nucleosome assembly | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 5 | 51 |
GO:0005681 | spliceosomal complex | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 55 |
GO:0007565 | female pregnancy | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 2 | 64 |
GO:0005200 | structural constituent of cytoskeleton | 4.11e-02 | 1.00e+00 | 4.581 | 1 | 2 | 68 |
GO:0030308 | negative regulation of cell growth | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 2 | 70 |
GO:0006325 | chromatin organization | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 3 | 70 |
GO:0001889 | liver development | 4.29e-02 | 1.00e+00 | 4.519 | 1 | 1 | 71 |
GO:0001649 | osteoblast differentiation | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 2 | 74 |
GO:0005815 | microtubule organizing center | 4.64e-02 | 1.00e+00 | 4.402 | 1 | 1 | 77 |
GO:0006006 | glucose metabolic process | 4.82e-02 | 1.00e+00 | 4.347 | 1 | 1 | 80 |
GO:0030529 | ribonucleoprotein complex | 4.94e-02 | 1.00e+00 | 4.311 | 1 | 4 | 82 |
GO:0005515 | protein binding | 5.22e-02 | 1.00e+00 | 0.981 | 5 | 76 | 4124 |
GO:0051607 | defense response to virus | 5.52e-02 | 1.00e+00 | 4.145 | 1 | 1 | 92 |
GO:0000086 | G2/M transition of mitotic cell cycle | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 5 | 97 |
GO:0009615 | response to virus | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 3 | 97 |
GO:0016887 | ATPase activity | 5.99e-02 | 1.00e+00 | 4.025 | 1 | 6 | 100 |
GO:0007507 | heart development | 6.34e-02 | 1.00e+00 | 3.941 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 6.34e-02 | 1.00e+00 | 3.941 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 6.51e-02 | 1.00e+00 | 3.900 | 1 | 3 | 109 |
GO:0008270 | zinc ion binding | 6.79e-02 | 1.00e+00 | 2.163 | 2 | 7 | 727 |
GO:0000287 | magnesium ion binding | 6.86e-02 | 1.00e+00 | 3.823 | 1 | 2 | 115 |
GO:0003924 | GTPase activity | 7.09e-02 | 1.00e+00 | 3.774 | 1 | 3 | 119 |
GO:0004672 | protein kinase activity | 7.44e-02 | 1.00e+00 | 3.703 | 1 | 2 | 125 |
GO:0006184 | GTP catabolic process | 7.73e-02 | 1.00e+00 | 3.646 | 1 | 3 | 130 |
GO:0003714 | transcription corepressor activity | 8.13e-02 | 1.00e+00 | 3.570 | 1 | 2 | 137 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.42e-02 | 1.00e+00 | 3.519 | 1 | 2 | 142 |
GO:0044281 | small molecule metabolic process | 8.86e-02 | 1.00e+00 | 1.947 | 2 | 32 | 844 |
GO:0005654 | nucleoplasm | 9.46e-02 | 1.00e+00 | 1.894 | 2 | 55 | 876 |
GO:0008380 | RNA splicing | 9.72e-02 | 1.00e+00 | 3.302 | 1 | 7 | 165 |
GO:0007067 | mitotic nuclear division | 9.72e-02 | 1.00e+00 | 3.302 | 1 | 8 | 165 |
GO:0007283 | spermatogenesis | 9.89e-02 | 1.00e+00 | 3.276 | 1 | 2 | 168 |
GO:0005634 | nucleus | 9.92e-02 | 1.00e+00 | 1.004 | 4 | 67 | 3246 |
GO:0043025 | neuronal cell body | 1.01e-01 | 1.00e+00 | 3.251 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 6 | 176 |
GO:0003677 | DNA binding | 1.08e-01 | 1.00e+00 | 1.781 | 2 | 18 | 947 |
GO:0005975 | carbohydrate metabolic process | 1.09e-01 | 1.00e+00 | 3.129 | 1 | 2 | 186 |
GO:0005525 | GTP binding | 1.15e-01 | 1.00e+00 | 3.046 | 1 | 5 | 197 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 1 | 203 |
GO:0006281 | DNA repair | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 19 | 203 |
GO:0019899 | enzyme binding | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 4 | 210 |
GO:0007275 | multicellular organismal development | 1.25e-01 | 1.00e+00 | 2.927 | 1 | 4 | 214 |
GO:0005813 | centrosome | 1.26e-01 | 1.00e+00 | 2.907 | 1 | 8 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 1.27e-01 | 1.00e+00 | 2.900 | 1 | 7 | 218 |
GO:0006351 | transcription, DNA-templated | 1.35e-01 | 1.00e+00 | 1.597 | 2 | 9 | 1076 |
GO:0003723 | RNA binding | 1.43e-01 | 1.00e+00 | 2.720 | 1 | 11 | 247 |
GO:0005730 | nucleolus | 1.66e-01 | 1.00e+00 | 1.419 | 2 | 41 | 1217 |
GO:0000278 | mitotic cell cycle | 1.78e-01 | 1.00e+00 | 2.374 | 1 | 35 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.80e-01 | 1.00e+00 | 2.360 | 1 | 7 | 317 |
GO:0005737 | cytoplasm | 2.02e-01 | 1.00e+00 | 0.891 | 3 | 50 | 2633 |
GO:0005783 | endoplasmic reticulum | 2.12e-01 | 1.00e+00 | 2.095 | 1 | 3 | 381 |
GO:0006915 | apoptotic process | 2.27e-01 | 1.00e+00 | 1.985 | 1 | 21 | 411 |
GO:0005794 | Golgi apparatus | 2.29e-01 | 1.00e+00 | 1.971 | 1 | 5 | 415 |
GO:0045087 | innate immune response | 2.48e-01 | 1.00e+00 | 1.848 | 1 | 7 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.49e-01 | 1.00e+00 | 1.836 | 1 | 4 | 456 |
GO:0010467 | gene expression | 2.87e-01 | 1.00e+00 | 1.605 | 1 | 31 | 535 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.08e-01 | 1.00e+00 | 1.484 | 1 | 6 | 582 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.36e-01 | 1.00e+00 | 1.338 | 1 | 8 | 644 |
GO:0005615 | extracellular space | 3.39e-01 | 1.00e+00 | 1.322 | 1 | 8 | 651 |
GO:0005886 | plasma membrane | 7.02e-01 | 1.00e+00 | -0.132 | 1 | 11 | 1784 |